Ben Synth explores how GLP-1 drugs like Ozempic and Wegovy are unexpectedly quieting addiction cravings—not just for food, but for alcohol, nicotine, and opioids. The episode digs into the neuroscience of reward circuits, the gut-brain axis, and why a diabetes medication might hold promise for treating substance use disorders by targeting shared craving architecture.
Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV
This content was created in partnership and with the help of Artificial Intelligence AI
Show More
Show Less